Amundi
DICE

Amundi’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Amundi’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,494
Closed -$116K – 2089
2023
Q2 		$116K Sell
2,494
-499
-17% -$17.2K ﹤0.01% 1738
2023
Q1 		$78.4K Hold
2,993
– – ﹤0.01% 1805
2022
Q4 		$88.3K Buy
+2,993
New +$97.6K ﹤0.01% 1630

Amundi's DICE Position: Q3 2023 in Review

Amundi sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 2,494 shares — an estimated $116K sold.

Amundi first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $116K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Amundi reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Amundi sold 2,494 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $116K.
  • Amundi first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Amundi's DICE Therapeutics, Inc. Common Stock position peaked at $116K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Amundi's 13F filing for Q3 2023, filed 14 Nov 2023.